Da Silva Jorge Santos, Chief Executive Officer at MoonLake Immunotherapeutics (MLTX), sold 200,000 shares at $14.49 ($3.0M) on 2025-12-09, disclosed to the SEC on 2025-12-10.
Open-market sale of $3.0M MLTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.08 | 130,000 | $2.0M | 65.9% |
| 2 | $14.49 | 70,000 | $1.0M | 34.1% |
| Total | $14.87 avg | 200,000 | $3.0M | 100% |
| Filing → |
| MLTX | SELL | 2026-04-14 | $2.8M | — | Filing → |
| MLTX | SELL | 2024-02-29 | $7.1M | — | Filing → |
| MLTX | SELL | 2024-02-23 | $124K | — | Filing → |